NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,669,334 | +141.0% | 919,081 | +165.0% | 0.13% | +142.3% |
Q2 2023 | $16,877,137 | +626.8% | 346,838 | +507.8% | 0.05% | +550.0% |
Q1 2022 | $2,322,000 | +469.1% | 57,067 | +1318.5% | 0.01% | +300.0% |
Q1 2021 | $408,000 | -93.9% | 4,023 | -94.0% | 0.00% | -93.1% |
Q4 2020 | $6,718,000 | +14.4% | 67,497 | -17.0% | 0.03% | +26.1% |
Q3 2020 | $5,874,000 | -32.8% | 81,311 | -53.6% | 0.02% | -47.7% |
Q2 2020 | $8,742,000 | +115.2% | 175,340 | +28.8% | 0.04% | +69.2% |
Q1 2020 | $4,063,000 | -33.9% | 136,081 | -25.4% | 0.03% | +30.0% |
Q4 2019 | $6,146,000 | +120.2% | 182,457 | +114.4% | 0.02% | +100.0% |
Q3 2019 | $2,791,000 | – | 85,104 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |